Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The newly proposed International Endocervical Adenocarcinoma Criteria and Classification and its relevance to cervical cytology screening assessed in a prospective 2-year study of 118 cases

O. Ondič, J. Němcová, R. Alaghehbandan, K. Černá, B. Gomolčáková, I. Kinkorová-Luňáčková, J. Chytra, H. Šidlová, M. Hósová, J. Bouda

. 2020 ; 31 (4) : 288-291. [pub] 20200614

Language English Country Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21026651

BACKGROUND: It is generally acknowledged that interobserver variability for the histological diagnosis of endocervical adenocarcinoma (EA) subtypes is suboptimal. The recently proposed International Endocervical Adenocarcinoma Criteria and Classification (IECC) system is based on the presence of associated human papilloma virus (HPV) infection. It recognises HPV-associated EAs and non-HPV-associated EAs. METHODS: This prospective cytology-histology and molecular genetics-based study investigated the potential effect of IECC being applied to Papanicolaou (Pap) test with regard to the diagnostic accuracy of severe glandular lesions reported at least as adenocarcinoma in situ (AIS). RESULTS: Out of 118 liquid-based cytology Pap tests with AIS+ lesion, complete information on follow-up biopsy and HPV status was available in 51 cases. AIS and EA category correlated with histologically confirmed AIS/EA in 88.5% (23/26) and 70.5% (12/17) of cases, respectively. Interestingly, 93% (40/43) of cases diagnosed as AIS/EA were HPV positive and 7% (3/43) were HPV negative (originating in the cervix, endometrium and adnexa). CONCLUSIONS: Our findings suggest that this approach could possibly divide Pap tests containing severe glandular lesion into two groups: (a) robust diagnosis of HPV-associated EA and (b) non-HPV associated glandular lesions of heterogeneous origin, requiring further clinical preoperative diagnostic workup.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026651
003      
CZ-PrNML
005      
20211026132723.0
007      
ta
008      
211013s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/cyt.12831 $2 doi
035    __
$a (PubMed)32289186
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Ondič, Ondrej $u Department of Pathology, Medical Faculty, Charles University Hospital Pilsen, Charles University, Pilsen, Czech Republic $u Bioptická laboratoř, s.r.o., Pilsen, Czech Republic
245    14
$a The newly proposed International Endocervical Adenocarcinoma Criteria and Classification and its relevance to cervical cytology screening assessed in a prospective 2-year study of 118 cases / $c O. Ondič, J. Němcová, R. Alaghehbandan, K. Černá, B. Gomolčáková, I. Kinkorová-Luňáčková, J. Chytra, H. Šidlová, M. Hósová, J. Bouda
520    9_
$a BACKGROUND: It is generally acknowledged that interobserver variability for the histological diagnosis of endocervical adenocarcinoma (EA) subtypes is suboptimal. The recently proposed International Endocervical Adenocarcinoma Criteria and Classification (IECC) system is based on the presence of associated human papilloma virus (HPV) infection. It recognises HPV-associated EAs and non-HPV-associated EAs. METHODS: This prospective cytology-histology and molecular genetics-based study investigated the potential effect of IECC being applied to Papanicolaou (Pap) test with regard to the diagnostic accuracy of severe glandular lesions reported at least as adenocarcinoma in situ (AIS). RESULTS: Out of 118 liquid-based cytology Pap tests with AIS+ lesion, complete information on follow-up biopsy and HPV status was available in 51 cases. AIS and EA category correlated with histologically confirmed AIS/EA in 88.5% (23/26) and 70.5% (12/17) of cases, respectively. Interestingly, 93% (40/43) of cases diagnosed as AIS/EA were HPV positive and 7% (3/43) were HPV negative (originating in the cervix, endometrium and adnexa). CONCLUSIONS: Our findings suggest that this approach could possibly divide Pap tests containing severe glandular lesion into two groups: (a) robust diagnosis of HPV-associated EA and (b) non-HPV associated glandular lesions of heterogeneous origin, requiring further clinical preoperative diagnostic workup.
650    _2
$a adenokarcinom $x klasifikace $x diagnóza $x patologie $x virologie $7 D000230
650    _2
$a dysplazie děložního hrdla $x klasifikace $x diagnóza $x patologie $x virologie $7 D002578
650    _2
$a cytodiagnostika $x metody $7 D003581
650    12
$a časná detekce nádoru $7 D055088
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a Papanicolaouův test $x metody $7 D065006
650    _2
$a infekce papilomavirem $x klasifikace $x diagnóza $x patologie $x virologie $7 D030361
650    _2
$a vaginální stěr $x metody $7 D014626
655    _2
$a časopisecké články $7 D016428
700    1_
$a Němcová, Jana $u Department of Pathology, Medical Faculty, Charles University Hospital Pilsen, Charles University, Pilsen, Czech Republic $u Bioptická laboratoř, s.r.o., Pilsen, Czech Republic
700    1_
$a Alaghehbandan, Reza $u Department of Pathology, Royal Columbian Hospital, University of British Columbia, Vancouver, BC, Canada
700    1_
$a Černá, Kateřina $u Department of Pathology, Medical Faculty, Charles University Hospital Pilsen, Charles University, Pilsen, Czech Republic $u Bioptická laboratoř, s.r.o., Pilsen, Czech Republic
700    1_
$a Gomolčáková, Barbora $u Bioptická laboratoř, s.r.o., Pilsen, Czech Republic
700    1_
$a Kinkorová-Luňáčková, Iva $u Bioptická laboratoř, s.r.o., Pilsen, Czech Republic
700    1_
$a Chytra, Jan $u Department of Gynecology and Obstetrics, Medical Faculty, Charles University Hospital Pilsen, Charles University, Pilsen, Czech Republic
700    1_
$a Šidlová, Henrieta $u Cytopathos, s.r.o., Bratislava, Slovak Republic $u Department of Pathology, Slovak Medical University, Bratislava, Slovak Republic
700    1_
$a Hósová, Marta $u Department of Pathology, Nemocnice Na Bulovce, Praha, Czech Republic
700    1_
$a Bouda, Jiří $u Department of Gynecology and Obstetrics, Medical Faculty, Charles University Hospital Pilsen, Charles University, Pilsen, Czech Republic
773    0_
$w MED00009532 $t Cytopathology : official journal of the British Society for Clinical Cytology $x 1365-2303 $g Roč. 31, č. 4 (2020), s. 288-291
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32289186 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026132729 $b ABA008
999    __
$a ok $b bmc $g 1715401 $s 1147158
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 31 $c 4 $d 288-291 $e 20200614 $i 1365-2303 $m Cytopathology $n Cytopathology $x MED00009532
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Archiving options